Internal Medicine, Hematology · Omaha, NE
NPI
1629416409
Since 2013
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
505 S. 45th St
Omaha, NE, 68198
Phone (402) 559-5600
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
809 services
Medicare patients, 2024
234
Average age 72
Drug cost, 2024
$1.9M
500 prescriptions
Company payments, 2025
$19K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher R D'Angelo was code 99233 (hospital e&m - subsequent), 267 times for 65 patients. In total Christopher R D'Angelo billed 809 services in 14 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-12-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 267 | 65 | $86.40 | $23K |
| 99215 Office E&M - Established | Facility | 144 | 58 | $98.07 | $14K |
| 99213 Office E&M - Established | Facility | 132 | 91 | $42.82 | $5,652 |
| 99214 Office E&M - Established | Facility | 85 | 58 | $62.57 | $5,319 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 53 | 35 | $12.12 | $642 |
| 99223 Hospital E&M - Initial | Facility | 46 | 37 | $123.32 | $5,673 |
| 99238 Hospital Discharge Management | Facility | 28 | 25 | $59.02 | $1,653 |
| 99205 Office E&M - New | Facility | 22 | 22 | $119.58 | $2,631 |
| 99239 Hospital Discharge Management | Facility | 20 | 18 | $83.48 | $1,670 |
By year: 2022 $52K for 638 services; 2023 $69K for 834 services; 2024 $61K for 809 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher R D'Angelo prescribed most often to Medicare patients was Acyclovir, with 94 prescriptions and refills. In total Christopher R D'Angelo wrote 500 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Acyclovir Generic | 94 | 143 | 28 | $1,183 |
| Revlimid Lenalidomide | 47 | 47 | Under 11 | $786K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 36 | 52 | 14 | $443 |
| Calquence Acalabrutinib Maleate | 30 | 30 | Under 11 | $400K |
| Allopurinol Generic | 18 | 20 | 16 | $38.54 |
| Ondansetron Hcl Generic | 14 | 14 | 12 | $64.09 |
| Prednisone Generic | 13 | 15 | Under 11 | $53.05 |
| Imbruvica Ibrutinib | 12 | 12 | Under 11 | $360K |
| Methotrexate Methotrexate Sodium | 11 | 11 | Under 11 | $14.1 |
| Infanrix Dtap Diph,pertuss(Acell),tet Ped/Pf | 11 | 11 | Under 11 | $279 |
Brand drugs: 186 claims; generic drugs: 314 claims; opioid claims: 20.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher R D'Angelo $19K ($19K in general payments such as food, travel and fees) from 9 companies. The largest payer was Adc Therapeutics America, Inc. with $15K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.